Loading…
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $1.5B | $262M | $160M | $46M | 19.9% | -14.3% | -209.3% |
| 2024 | $1.7B | $-79M | $-147M | $70M | -22.5% | -12.0% | -1805.6% |
| 2023 | $2.0B | $123M | $9M | $60M | 1.0% | -11.5% | -91.8% |
| 2022 | $2.2B | $175M | $105M | $49M | 11.7% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 2,225.66 | 1,969.13 | 1,732.08 | 1,485.16 |
| Operating Revenue | - | 2,225.66 | 1,969.13 | 1,732.08 | 1,485.16 |
| Cost Of Revenue | - | 630.92 | 611.85 | 550.23 | 453.76 |
| Gross Profit | - | 1,594.74 | 1,357.28 | 1,181.85 | 1,031.40 |
| Operating Expense | - | 1,435.40 | 1,289.22 | 1,131.08 | 940.52 |
| Selling General And Administration | - | 1,435.40 | 1,289.22 | 1,131.08 | 940.52 |
| Total Expenses | - | 2,066.32 | 1,901.07 | 1,681.31 | 1,394.28 |
| Operating Income | - | 159.34 | 68.06 | 50.78 | 90.88 |
| Total Operating Income As Reported | - | 110.85 | 48.27 | -151.58 | 65.76 |
| EBITDA | - | 174.97 | 123.06 | -78.83 | 262.41 |
| Normalized EBITDA | - | 223.46 | 142.85 | 123.53 | 111.36 |
| EBIT | - | 102.46 | 52.14 | -148.64 | 210.14 |
| Interest Expense | - | 13.49 | 25.56 | 26.41 | 13.95 |
| Net Interest Income | - | -13.49 | -25.56 | -26.41 | -13.95 |
| Other Non Operating Income Expenses | - | -8.38 | 3.87 | 2.94 | -31.78 |
| Other Income Expense | - | -56.88 | -15.92 | -199.42 | 119.27 |
| Interest Expense Non Operating | - | 13.49 | 25.56 | 26.41 | 13.95 |
| Net Non Operating Interest Income Expense | - | -13.49 | -25.56 | -26.41 | -13.95 |
| Pretax Income | - | 88.97 | 26.58 | -175.05 | 196.20 |
| Tax Provision | - | -15.81 | 17.98 | -28.46 | 35.99 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -10.18 | -4.16 | -32.98 | 27.72 |
| Net Income Continuous Operations | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Net Income From Continuing And Discontinued Operation | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Net Income From Continuing Operation Net Minority Interest | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Net Income | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Net Income Common Stockholders | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Net Income Including Noncontrolling Interests | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Normalized Income | - | 143.09 | 24.23 | 22.78 | 36.87 |
| Diluted NI Availto Com Stockholders | - | 104.78 | 8.60 | -146.59 | 160.20 |
| Basic Average Shares | - | 50 | 49.71 | 49.66 | 49.29 |
| Diluted Average Shares | - | 50.52 | 49.86 | 49.66 | 50.30 |
| Reconciled Depreciation | - | 72.51 | 70.92 | 69.81 | 52.26 |
| Reconciled Cost Of Revenue | - | 630.92 | 611.85 | 550.23 | 453.76 |
| Total Unusual Items | - | -48.49 | -19.79 | -202.36 | 151.05 |
| Total Unusual Items Excluding Goodwill | - | -48.49 | -19.79 | -202.36 | 151.05 |
| Special Income Charges | - | -48.49 | -19.79 | -202.36 | 151.05 |
| Gain On Sale Of Business | - | - | 0 | 0 | 176.16 |
| Restructuring And Mergern Acquisition | - | 48.49 | 19.79 | 202.36 | 25.11 |
| General And Administrative Expense | - | 555.77 | 546.86 | 479.04 | 432.14 |
| Other Gand A | - | 555.77 | 546.86 | 479.04 | 432.14 |
| Selling And Marketing Expense | - | 879.63 | 742.36 | 652.04 | 508.38 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Nu Skin Enterprises, Inc.this co. | NUS | $258M | 1.61↓ discount | 0.32 | 19.9% | 1.24 |
| USANA Health Sciences, Inc. | USNA | $335M | 31.11 | 0.63 | 2.0% | 2.39 |
| B&G Foods, Inc. | BGS | $321M | - | 0.71 | -9.6% | 12.03 |
| European Wax Center, Inc. | EWCZ | $319M | 36.76 | 4.03 | 11.0% | 9.88 |
| Alico, Inc. | ALCO | $300M |
| - |
| - |
| - |
| - |
| - |
| - |
| -2.03 |
| 2.91 |
| -143.0% |
| -78.12 |
| Franklin Covey Co. | FC | $270M | 87.92 | 4.03 | 4.6% | 15.21 |
| Forafric Global PLC | AFRI | $268M | -18.02 | -30.88 | 171.4% | 40.65 |
| Waldencast plc | WALD | $224M | - | 0.35 | -49.7% | - |
| Limoneira Company | LMNR | $215M | -13.45 | 1.34 | -9.9% | -28.00 |
| Peer Median | - | 14.54 | 1.02 | -3.8% | 9.88 | |